Chao Liang
Hong Kong Baptist University(HK)Hunan University(CN)Second Military Medical University(CN)Anhui University of Science and Technology(CN)Southern University of Science and Technology(CN)Wuhan University(CN)Huainan Normal University(CN)Shenzhen Institute for Drug Control(CN)Beijing Proteome Research Center(CN)Hainan Provincial Hospital of Traditional Chinese Medicine(CN)State Key Laboratory of Chemobiosensing and ChemometricsState Key Laboratory of ProteomicsHainan Medical University(CN)
Publications by Year
Research Areas
Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery, Bone Metabolism and Diseases, MicroRNA in disease regulation, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation(2016)582 cited
- → Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy(2015)343 cited
- → Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis(2021)316 cited
- → A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer(2017)278 cited
- → Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma(2017)207 cited
- → A newly identified lncRNA MAR1 acts as a miR‐487b sponge to promote skeletal muscle differentiation and regeneration(2018)195 cited